Sonoma Pharmaceuticals (SNOA) Interest & Investment Income (2010 - 2021)
Sonoma Pharmaceuticals (SNOA) recorded quarterly Interest & Investment Income of $2000.0 in Q1 2021, down 33.33% quarter-over-quarter from $3000.0 in Q4 2020, and up 102.99% on a YoY basis from $985.29 in Q1 2020.
Sonoma Pharmaceuticals (SNOA) Interest & Investment Income (2010 - 2021) Analysis & Trends
Sonoma Pharmaceuticals' Interest & Investment Income history runs 12 years deep, the most recent figure standing at $2000.0 for Q1 2021.
- In Q1 2021, Interest & Investment Income rose 102.99% year-over-year to $2000.0; the TTM figure through Mar 2021 stood at $15000.0 (down 70.0% YoY), while the FY2021 annual figure was $16000.0, down 68.0% from the prior year.
- Interest & Investment Income was $2000.0 for Q1 2021 at Sonoma Pharmaceuticals, down from $3000.0 in the prior quarter.
- In the past five years, Interest & Investment Income ranged from a high of $173000.0 in Q1 2018 to a low of -$67000.0 in Q1 2020.
- Historically, Interest & Investment Income has averaged $31000.0 across 5 years, with a median of $33000.0 in 2019.
- The sharpest annual moves came in 2017 and 2020: Interest & Investment Income surged 5200.0% in 2017, then slumped 231.37% in 2020.
- A 5-year view of Interest & Investment Income shows it stood at $14000.0 in 2017, then soared by 164.29% to $37000.0 in 2018, then retreated by 10.81% to $33000.0 in 2019, then slumped by 90.91% to $3000.0 in 2020, then sank by 33.33% to $2000.0 in 2021.
- The last three Interest & Investment Income figures came in at $2000.0 (Q1 2021), $3000.0 (Q4 2020), and $8000.0 (Q3 2020), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.77 Bn | 35.04 Bn | 1.97 Bn | - |
| 2 | Zoetis | 34.11 Bn | 32.16 Bn | 1.62 Bn | - |
| 3 | United Therapeutics | 23.68 Bn | 21.53 Bn | 648.10 Mn | 41.80 Mn |
| 4 | Aurora Cannabis | 16.48 Bn | 16.40 Bn | 33.43 Mn | 3.45 Mn |
| 5 | Neurocrine Biosciences | 16.19 Bn | 14.88 Bn | 800.70 Mn | 28.10 Mn |
| 6 | Elanco Animal Health | 11.44 Bn | 11.01 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.28 Bn | 6.77 Bn | -116.06 Mn | 8.54 Mn |
| 8 | Lantheus Holdings | 6.48 Bn | 5.98 Bn | 230.92 Mn | 4.97 Mn |
| 9 | Hims & Hers Health | 6.35 Bn | 5.60 Bn | 396.79 Mn | - |
| 10 | Sonoma Pharmaceuticals | 1.87 Mn | -693,829.94 | 1.65 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2021 | 2,000.00 |
| Dec 31, 2020 | 3,000.00 |
| Sep 30, 2020 | 8,000.00 |
| Jun 30, 2020 | 2,000.00 |
| Mar 31, 2020 | -67,000.00 |
| Dec 31, 2019 | 33,000.00 |
| Sep 30, 2019 | 42,000.00 |
| Jun 30, 2019 | 42,000.00 |
| Mar 31, 2019 | 51,000.00 |
| Dec 31, 2018 | 37,000.00 |
| Sep 30, 2018 | 47,000.00 |
| Jun 30, 2018 | 55,000.00 |
| Mar 31, 2018 | 173,000.00 |
| Dec 31, 2017 | 14,000.00 |
| Sep 30, 2017 | 18,000.00 |
| Jun 30, 2017 | 53,000.00 |
| Mar 31, 2017 | 14,000.00 |
| Dec 31, 2016 | 6,000.00 |
| Sep 30, 2016 | 1,000.00 |
| Jun 30, 2016 | 1,000.00 |